The Calcium Channel: Structure Function and Implications : Bayer Ag Centenary Symposium Stresa/Italy, May 11-14, 1988
Health - The Post Chronicle (Free subscription) | yesterday
A U.S. Food and Drug Administration review found the risk of a serious skin disorder is greater with MRI imaging contrast agents made by GE Healthcare, Bayer AG's and Covidien....
Reuters UK (Free subscription) | 11/25/2009
WASHINGTON (Reuters) - A U.S. Food and Drug Administration review found the risk of a serious skin disorder is greater with MRI imaging contrast agents made by GE Healthcare, Bayer AG's and Covidien, according to an agency memo released on Wednesday.
NewsInferno (Free subscription) | 11/25/2009
Yaz, Bayer Healthcare’s popular birth control pill, has been blamed for causing several pulmonary emboli that nearly killed a 16-year-old Pennsylvania girl. The young woman’s mother has filed a personal injury lawsuit against Bayer on her daughter’s behalf, alleging that Yaz was responsible for her daughter’s severe and lasting injuries. More than 100 lawsuits have [...]
Hindu (Free subscription) | 11/24/2009
HYDERABAD: Bayer Crop Science and GVK Biosciences Pvt. Ltd. (GVK Bio), Hyderabad, have entered into a research co-operation in the area of early discovery chemistry. The objective is to speed up the search for promising active ingredients for ...
prsync (Free subscription) | 11/24/2009
Bayer press release - Cooperation with Asia’s leading contract research organization: -- Bayer CropScience is working with GVK Biosciences on early-stage research projects
Business Wire (Free subscription) | 11/23/2009
PITTSBURGH--(BUSINESS WIRE)--Wendy R. Fleishman of the national plaintiffs' law firm Lieff Cabraser Heimann & Bernstein, LLP announced that Dana Kraus, on behalf of her sixteen-year old daughter, Katie Kraus, filed a personal injury lawsuit against Bayer Healthcare Pharmaceutical Corporation for severe and lasting injuries caused by Bayer's prescription drug Yaz. The lawsuit was filed in the Court...
bharatbook | 11/21/2009
Bayer AG (Bayer) is the management holding company for the Bayer Group. The company carries out its operations through three business segments, namely, Bayer HealthCare, Bayer CropScience and Bayer MaterialScience. The major products offered by the company include, ethical pharmaceuticals and other healthcare products, polymers and agricultural products. During 2008, Bayer launched its new anticoagulant
The Sloman Economics News Site (Free subscription) | 11/20/2009
The National Institute for Health and Clinical Excellence (NICE) is the independent agency in the UK charged, amongst other things, with assessing the cost-effectiveness of new drugs. In a report published on 19 November 2009, NICE found that the drug sorafenib, branded as Nexavar by its manufacturer, the German pharmaceutical company, Bayer AG, was [...]
PharmaGossip (Free subscription) | 11/20/2009
Justice Department Recovers $2.4 Billion in False Claims Cases in Fiscal Year 2009; More Than $24 Billion Since 1986 FY09 Recovery is Second Largest in History WASHINGTON, Nov. 19 /PRNewswire-USNewswire/ -- The United States secured $2.4 billion in settlements and judgments in cases involving fraud against the government in the fiscal year ending Sept. 30, 2009, the Justice Department announced today....
Business Wire (Free subscription) | 11/20/2009
NEW YORK--(BUSINESS WIRE)--Wendy R. Fleishman of the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP announced that Mae Walker today filed a personal injury lawsuit against Bayer Healthcare Pharmaceuticals, Inc., for severe and lasting injuries caused by Bayer’s birth control drug Yaz. Walker’s complaint charges that Yaz is a dangerous prescription drug sold...
All Africa (Free subscription) | 11/19/2009
THE legal action instituted against Bayer CropScience AG by farmers in the United States for allegedly contaminating their farms with Genetically Modified (GM) rice seeds in 2006 is a further confirmation of the validity of tests carried out on rice samples collected by the Environmental Rights Action/Friends of the Earth Nigeria (ERA/FoEN) in Nigeria and other West African countries within the same...
Fiercebiotech (Free subscription) | 11/19/2009
Bayer HealthCare and Johnson & Johnson have good news to present about their blood-thinner Xarelto--a potential blockbuster that the FDA declined to approve months ago. Results from a long-term clinical trial showed taking Xarelto led to an 82 percent lower risk that a venous blood clot would form again compared with placebo, according to a Reuters article. The Phase III EINSTEIN-extension study...
NewsInferno (Free subscription) | 11/18/2009
Three gadolinium contrast dyes – Bayer Healthcare’s Magnevist, GE Healthcare’s Omniscan, and Covidien ’s OptiMARK -carry a higher risk of nephrogenic systemic fibrosis (NSF) than other agents on the market, according to the U.S. Food & Drug Administration (FDA). Though the agency’s drug safety unit said the risk associated with the gadolinium [...]
AboutLawsuits.com (Free subscription) | 11/13/2009
U.S. District Judge David R. Herndon, who is presiding over the federal litigation for Yaz and Yasmin birth control, has appointed a group of attorneys to serve in leadership roles, and perform certain actions on behalf of all plaintiffs who have filed a Yaz lawsuit or Yasmin lawsuit against Bayer Healthcare Pharmaceuticals. In October, [...]
Fiercebiotech (Free subscription) | 11/12/2009
Bayer will be increasing its R&D spending in 2010 and enter alliances to fight diseases like TB that largely affect developing nations, according to Werner Wenning ( photo ), the German group's chairman. Speaking at the firm's Perspective on Sustainability press conference in Leverkusen, Wenning noted that Bayer's R&D expenditure is likely to rise next year from its 2009 level of €2.9...
The 3 latest articles published by users on Bayer AG :
bharatbook | 11/21/2009
Bayer AG (Bayer) is the management holding company for the Bayer Group. The company carries out its operations through three business segments, namely, Bayer HealthCare, Bayer CropScience and Bayer MaterialScience. The major products offered by the company include, ethical pharmaceuticals and other healthcare products, polymers and agricultural products. During 2008, Bayer launched its new anticoagulant
aarkstore | 11/11/2009
Summary This Medical Device report is an essential source for key information and data relating to the global Diabetes Care Devices market. The report provides overview of key trends, regulatory information in key countries, pricing & reimbursement, drivers and restraints, future outlook, pipeline products, news, financial deals and competitive landscape and key developments in the global Diabetes...
aarkstore | 09/07/2009
POF (Plastic Optical Fiber) Sourcebook More than Just a Directory The "POF Sourcebook" is the first complete compilation of companies, research and development centers, Universities and other organizations that have been involved in the research, development, production, and marketing of Plastic Optical Fiber components, subsystems and systems for data applications. A major void in the Plastic Optical...
Videos